Jian Zhou

Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection

Xiaoqiang Chai, Longfei Hu, Yan Zhang et al. · 2020 · 981 citations · Full text

Immunology, Pathology, Liver Dysfunction +23

Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma

Qiang Gao, Xiaoying Wang, Shuang‐Jian Qiu et al. · Clinical Cancer Research · 2009 · 811 citations · Full text

Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma

Zijian Yang, Cong Yan, Jiaqiang Ma et al. · Nature Metabolism · 2023 · 475 citations

Lactylome Analysis, Liver, Hepatology +14

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Neutrophil profiling illuminates anti-tumor antigen-presenting potency

Yingcheng Wu, Jiaqiang Ma, Xupeng Yang et al. · Cell · 2024 · 342 citations

Inflammation, Immune Evasion, Cancer Immunosurveillance +6